TTNP

Titan Pharmaceuticals, Inc.

6.61 USD
+0.16 (+2.48%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Titan Pharmaceuticals, Inc. stock is down -9.7% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 43.75% of the previous 15 May’s closed higher than April.

About Titan Pharmaceuticals, Inc.

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company was incorporated in 1992 and is based in South San Francisco, California.